Restless legs symptoms may predict adverse cardiovascular outcomes in men with CAD: Study

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2021-12-21 04:45 GMT | Update On 2021-12-21 05:58 GMT

USA: A recent study has reported that moderate-to-severe restless legs syndrome (RLS) symptoms are related to a significantly higher risk of adverse cardiovascular outcomes in men with coronary artery disease (CAD). The study appears in The American Journal of Cardiology.

In the general population, the association between RLS and cardiovascular disease (CVD) remains confusing and its prognostic value in CAD patients is not known. To fill this knowledge gap, Arshed A. Quyyumi, Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, and colleagues aimed to assess the frequency of RLS-like symptoms in 3,266 patients undergoing cardiac catheterization using a validated instrument.

Patients were followed for primary endpoints of incident myocardial infarction or cardiovascular death. The association between RLS and incident events was explored after adjusting for demographic and clinical risk factors.

The study revealed the following findings:

In the total cohort, 29% of patients reported mild (rare or sometimes) symptoms, and 15% of patients had moderate/severe (often to almost always) symptoms of RLS.
Female sex (odds ratio [OR] 2.11), body mass index (OR 1.12 per 5 kg/m²), diabetes (OR 1.43), and β-blocker use (OR 1.35) were independently associated with moderate/severe symptoms of RLS compared with no symptoms.
Over a 5-year follow-up period, 991 patients suffered an adverse event.
Compared with those with no symptoms, patients with moderate/severe RLS had a significantly higher risk of the primary endpoint (hazard ratio [HR] = 1.33) after adjustment for demographic and clinical risk factors.
The association was more significant in men than women, HR 1.98 versus HR 0.99.

"We found that among men with CAD, moderate-to-severe symptoms of RLS are associated with a significantly higher risk of adverse cardiovascular outcomes, independent of traditional risk factors," wrote the authors.

Reference:

The study titled, "Usefulness of Restless Legs Symptoms to Predict Adverse Cardiovascular Outcomes in Men With Coronary Artery Disease," is published in The American Journal of Cardiology.

DOI: https://doi.org/10.1016/j.amjcard.2021.08.054

Article Source : American Journal of Cardiology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medha Baranwal

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Restless legs symptoms may predict adverse cardiovascular outcomes in men with CAD: Study

Similar News

Women With Pre-Pregnancy Chronic Conditions Face Greater Risk of Severe Maternal Complications: Study Shows

De-escalation of DAPT provides benefits in patients after CABG: ESC Study

Abelacimab Cuts Bleeding Risk in AF Patients Regardless of Kidney Function: AZALEA-TIMI 71 Analysis

Post MI Beta blockers may offer no benefit for heart attack patients and women can have worse outcomes: ESC Study

WHO Expands 2025 Essential Medicines List, Adding Life-Saving Cancer and Diabetes Treatments

Monthly Olezarsen Significantly Lowers Triglycerides in High-Risk Patients: NEJM

GLP-1 Receptor Agonists Improve Metabolic Outcomes in Schizophrenia Patients on Antipsychotics: JAMA

Some mental conditions raise heart disease risk, mortality rate by nearly 100%, reveals study